What is Vericel?
Vericel Corporation, formerly Aastrom Biosciences, Inc., is a biopharmaceutical firm established in 1989 and headquartered in Cambridge, Massachusetts. The company specializes in the development, manufacturing, and commercialization of innovative cell therapies and specialty biologic products. Vericel primarily targets the sports medicine and severe burn care markets within North America. Its product portfolio includes autologous cell therapy solutions and a licensed specialty biologic for burn treatment, distributed through orthopedic surgeons, sports medicine specialists, and dedicated burn care centers. The company's strategy involves merging cell biology advancements with medical technology to create differentiated therapies aimed at injury repair and the management of serious medical conditions.
How much funding has Vericel raised?
Vericel has raised a total of $313.8M across 14 funding rounds:
Stock Offering
$12.4M
Stock Offering
$20.5M
Share Placement
$38M
Stock Offering
$9M
Private Equity
$15M
Stock Offering
$40.3M
Stock Offering
$20M
Debt
$25M
Stock Offering
$74.8M
Stock Issuance/Offering (2010): $12.4M with participation from Undisclosed
Stock Issuance/Offering (2010): $20.5M led by Undisclosed
Share Placement (2012): $38M supported by Eastern Capital
Stock Issuance/Offering (2013): $9M featuring Undisclosed
Private Equity (2014): $15M backed by Lincoln Park Capital
Stock Issuance/Offering (2014): $40.3M with participation from Undisclosed
Stock Issuance/Offering (2016): $20M led by Undisclosed
Debt (2017): $25M supported by Silicon Valley Bank and MidCap Financial
Stock Issuance/Offering (2018): $74.8M featuring Undisclosed
Key Investors in Vericel
Silicon Valley Bank
Silicon Valley Bank, founded in 1983 and headquartered in Santa Clara, California, is a financial institution offering a comprehensive suite of commercial and private banking, asset management, and investment services. They are known for supporting technology and life science companies.
MidCap Financial
MidCap Financial specializes in providing tailored and efficient financing solutions to businesses. They focus on quickly addressing opportunities with flexible capital, aiming to support client growth and operational needs.
National Institutes of Health
The National Institutes of Health, established in 1887 and based in Bethesda, Maryland, is the primary U.S. agency for biomedical and health-related research, providing grants and funding to advance scientific understanding and medical treatments.
What's next for Vericel?
The recent major strategic investment of $74.8M positions Vericel for significant expansion, likely indicating a growth or scaling phase in its enterprise-level funding trajectory. This capital injection is anticipated to accelerate the company's research and development pipeline, enhance its manufacturing capabilities, and broaden its market reach for its advanced cell therapies. Strategic partnerships and potential acquisitions may also be on the horizon as Vericel aims to solidify its leadership in the biopharmaceutical sector, particularly in sports medicine and severe burn care.
See full Vericel company page
